rly-2608
relay therapeutics
['rly2608 ']
#rly2608 activity in phase 1. single pr so far, notably in patient with double pik3ca mutations. glucose levels extremely stable in cohort. no dlts, and mtd not reached. dose escalation ongoing. #aacr23 
Director, Kabara Cancer Research Institute; Dr. Jon & Betty Kabara Endowed Chair in Precision Oncology. Gundersen Medical Foundation. Opinions are my own.